By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A lung cancer drug reduced the risk of death by 34% in a late-stage trial, in the latest sign of China’s pharmaceutical ...

Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth.

The American Cancer Society’s annual cancer trends report revealed a mix of news and statistics for 2025. Cancer death rates have dropped 34% between 1991 and 2022, which the ACS attributes to early ...

Colorectal cancer has become the leading cause of cancer death among people under 50 in the United States – and the reasons why are still murky, a new report says. In the early 1990s, colorectal ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...

If this was my house and I wasn’t remediating this, you better believe the government would come in and take my property,' ...

Lung cancer may not be the most common cancer diagnosis in the United States—that would be prostate cancer for men and breast ...